| 000 | 01701 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515114858.0 | ||
| 264 | 0 | _c20081031 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1573-6903 | ||
| 024 | 7 |
_a10.1007/s11064-008-9605-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDurmaz, Ramazan | |
| 245 | 0 | 0 |
_aThe protective effect of dexanabinol (HU-211) on nitric oxide and cysteine protease-mediated neuronal death in focal cerebral ischemia. _h[electronic resource] |
| 260 |
_bNeurochemical research _cSep 2008 |
||
| 300 |
_a1683-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain Ischemia _xmetabolism |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 | _aCathepsin L |
| 650 | 0 | 4 |
_aCathepsins _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aCerebral Cortex _xcytology |
| 650 | 0 | 4 |
_aCysteine Endopeptidases _xmetabolism |
| 650 | 0 | 4 |
_aDronabinol _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 | _aInfarction, Middle Cerebral Artery |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNitrates _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitrites _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aOzden, Hilmi | |
| 700 | 1 | _aKanbak, Güngör | |
| 700 | 1 | _aAral, Erinç | |
| 700 | 1 | _aArslan, Okan Can | |
| 700 | 1 | _aKartkaya, Kazim | |
| 700 | 1 | _aUzuner, Kubilay | |
| 773 | 0 |
_tNeurochemical research _gvol. 33 _gno. 9 _gp. 1683-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11064-008-9605-0 _zAvailable from publisher's website |
| 999 |
_c17902787 _d17902787 |
||